Product image of Kanpiduo (Indapamide, Candesartan Cilexetil) supplied by GNH India

Kanpiduo

Active Ingredient:
Indapamide, Candesartan Cilexetil
Origin:
EU

Kanpiduo (Indapamide, Candesartan Cilexetil)

Indapamide and Candesartan cilexetil, the active ingredients in Kanpiduo, are a thiazide‑like diuretic and an angiotensin II receptor antagonist presented as a tablet for oral use. They are prescribed to lower elevated blood pressure in adults.
GNH India supplies Kanpiduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kanpiduo, a combination antihypertensive, is employed to control high blood pressure in patients with primary hypertension.

  • Hypertension: lowers systolic and diastolic blood pressure and helps achieve target blood pressure goals.
  • Essential hypertension: provides sustained blood pressure control when monotherapy is insufficient.
  • Secondary hypertension (renovascular): assists in managing blood pressure when combined with other antihypertensive agents.

How It Works

  • Indapamide inhibits sodium‑chloride reabsorption in the distal renal tubule, promoting diuresis and reducing plasma volume. Candesartan cilexetil blocks angiotensin II type‑1 (AT1) receptors, preventing vasoconstriction and aldosterone release, which together produce vasodilation and further reduction of arterial pressure.

Side Effects

Kanpiduo may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: feeling light‑headed, especially after standing.
  • Headache: mild to moderate intensity.
  • Fatigue: general tiredness or lack of energy.
  • Increased urination: due to the diuretic component.
  • Electrolyte imbalance: especially low potassium or sodium.
  • Cough: occasional dry throat irritation.

Serious or Rare Side Effects

  • Severe hypotension: marked drop in blood pressure causing fainting.
  • Hyperkalemia: elevated potassium levels that may affect heart rhythm.
  • Acute kidney injury: sudden decline in renal function.
  • Angioedema: swelling of face, lips, or throat.
  • Liver enzyme elevation: abnormal liver function tests.
  • Allergic reactions: rash, itching, or severe skin reactions.

Precautions & Warnings

Before initiating Kanpiduo, several safety considerations should be observed.

  • Blood pressure monitoring: check baseline and periodic readings.
  • Electrolyte assessment: evaluate serum potassium and sodium levels.
  • Renal function: assess creatinine clearance, especially in elderly patients.
  • Hepatic disease: use with caution in moderate to severe liver impairment.
  • Drug interactions: review concomitant medications for potential additive effects.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Kanpiduo can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics: risk of hyperkalemia.
  • ACE inhibitors or other ARBs: additive blood‑pressure lowering effect.
  • Lithium: increased lithium levels and toxicity.
  • NSAIDs: may blunt antihypertensive effect and impair renal function.
  • Aliskiren (in diabetics): heightened risk of hypotension and renal impairment.

Moderate Interactions (Monitor Closely)

  • Other antihypertensives: monitor for excessive hypotension.
  • CYP2C9 inhibitors (e.g., fluconazole): may increase candesartan levels.
  • Loop diuretics: watch electrolyte balance and renal function.

Frequently Asked Questions

Kanpiduo is a prescription medication that combines indapamide and candesartan cilexetil to treat hypertension. It helps lower elevated systolic and diastolic blood pressure, reducing the risk of cardiovascular complications associated with high blood pressure.

Indapamide acts as a thiazide‑like diuretic, inhibiting sodium‑chloride reabsorption in the distal tubule, which increases urine output and reduces plasma volume. Candesartan cilexetil blocks angiotensin II type‑1 receptors, preventing vasoconstriction and aldosterone release, leading to vasodilation and further blood‑pressure reduction.

The specific dose of Kanpiduo is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Kanpiduo in pregnancy or while breastfeeding has not been fully established. Healthcare providers should weigh potential benefits against risks and consider alternative treatments if appropriate. Women who are pregnant, planning pregnancy, or nursing should discuss options with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kanpiduo combines a diuretic and an angiotensin II receptor blocker, offering a dual mechanism that can be more effective than monotherapy for patients who need additional blood‑pressure control. Compared with single‑agent therapies, the combination may simplify dosing and improve adherence while targeting two complementary pathways.

Kanpiduo tablets should be stored at ambient temperature below 25 °C, kept in the original packaging, and protected from moisture and direct sunlight. Do not store in humid environments or expose the tablets to excessive heat.

Kanpiduo is taken orally, usually once daily, with or without food as directed by a healthcare professional. Swallow the tablet whole with a glass of water and do not crush or chew it unless instructed otherwise.

Serious risks include severe hypotension, hyperkalemia, acute kidney injury, and angioedema. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling of the face or throat, or any signs of kidney dysfunction.

Kanpiduo is contraindicated in patients with known hypersensitivity to indapamide, candesartan, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, hyperkalemia, or those taking potassium‑sparing diuretics without close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Indapamide, Candesartan Cilexetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT